Literature DB >> 7180966

Chronic granulomatous disease of childhood presenting as gastric outlet obstruction.

V A Varma, J T Sessions, L B Kahn, S Lipper.   

Abstract

A case of chronic granulomatous disease of childhood was first diagnosed when a 20-month-old infant developed gastric outlet obstruction. Because of the unusual clinical presentation and negative gastric mucosal biopsies, the diagnosis was delayed. A subsequent full thickness biopsy of the stomach wall which led to a correct diagnosis showed a granulomatous infiltrate in the muscularis propria. Characteristic yellow pigment-laden macrophages were seen in the gastric mucosa and pyloric lymph node. Early recognition of this chronic disorder is important not only for proper management but genetic counseling as well.

Entities:  

Mesh:

Year:  1982        PMID: 7180966     DOI: 10.1097/00000478-198210000-00009

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  9 in total

1.  Infantile myofibromatosis: a most unusual cause of gastric outlet obstruction.

Authors:  Kellie Rohrer; Robyn Murphy; Caroline Thresher; Nabil Jacir; Kerry Bergman
Journal:  Pediatr Radiol       Date:  2005-04-20

2.  Chronic granulomatous disease of childhood: gastric manifestation and response to salazosulfapyridine therapy.

Authors:  J Stopyrowa; K Fyderek; B Sikorska; D Kowalczyk; M Zembala
Journal:  Eur J Pediatr       Date:  1989-10       Impact factor: 3.183

3.  Idiopathic non-hypertrophic pyloric stenosis in an infant successfully treated via endoscopic approach.

Authors:  Wikrom Karnsakul; Mary L Cannon; Stacey Gillespie; Richard Vaughan
Journal:  World J Gastrointest Endosc       Date:  2010-12-16

Review 4.  Pathology of non-Helicobacter pylori gastritis: extending the histopathologic horizons.

Authors:  Gregory Y Lauwers; Hiroshi Fujita; Koji Nagata; Michio Shimizu
Journal:  J Gastroenterol       Date:  2009-12-05       Impact factor: 7.527

5.  Host defense molecule polymorphisms influence the risk for immune-mediated complications in chronic granulomatous disease.

Authors:  C B Foster; T Lehrnbecher; F Mol; S M Steinberg; D J Venzon; T J Walsh; D Noack; J Rae; J A Winkelstein; J T Curnutte; S J Chanock
Journal:  J Clin Invest       Date:  1998-12-15       Impact factor: 14.808

6.  Chronic granulomatous disease: a review of the infectious and inflammatory complications.

Authors:  Eunkyung Song; Gayatri Bala Jaishankar; Hana Saleh; Warit Jithpratuck; Ryan Sahni; Guha Krishnaswamy
Journal:  Clin Mol Allergy       Date:  2011-05-31

Review 7.  Understanding inborn errors of immunity: A lens into the pathophysiology of monogenic inflammatory bowel disease.

Authors:  Jodie Deborah Ouahed
Journal:  Front Immunol       Date:  2022-09-29       Impact factor: 8.786

8.  Managing Inflammatory Manifestations in Patients with Chronic Granulomatous Disease.

Authors:  Alessandra Magnani; Nizar Mahlaoui
Journal:  Paediatr Drugs       Date:  2016-10       Impact factor: 3.930

9.  Very Early-Onset Inflammatory Manifestations of X-Linked Chronic Granulomatous Disease.

Authors:  Roxane Labrosse; Jane Abou-Diab; Annaliesse Blincoe; Guilhem Cros; Thuy Mai Luu; Colette Deslandres; Martha Dirks; Laura Fazilleau; Philippe Ovetchkine; Pierre Teira; Françoise LeDeist; Isabel Fernandez; Fabien Touzot; Helene Decaluwe; Ugur Halac; Elie Haddad
Journal:  Front Immunol       Date:  2017-09-26       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.